| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/06/2000 | CN1056154C Method of producing reconstituted lipoproteins |
| 09/06/2000 | CN1056153C Peptide inhibitors of mitogenesis and motorgenesis |
| 09/06/2000 | CN1056141C 哌嗪衍生物 Piperazine derivatives |
| 09/06/2000 | CN1056083C Method and compositions for treatment and repair of defects or lesions in cartilage |
| 09/06/2000 | CN1056082C Anticancer drug |
| 09/05/2000 | US6114609 Corn inbred lines for dairy cattle feed |
| 09/05/2000 | US6114599 Producing glucose regulated insulin producing cells whose proliferation is regulated by tetracycline; introducing into cells a tetracycline fusion protein gene, an insulin promoter and a gene encoding an sv40 antigen and tetracycline promoter |
| 09/05/2000 | US6114598 Generation of xenogeneic antibodies |
| 09/05/2000 | US6114517 Methods of modulating tumor necrosis factor α-induced expression of cell adhesion molecules |
| 09/05/2000 | US6114516 Nucleotide sequences coding for variable regions of the αchains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic muses |
| 09/05/2000 | US6114515 PIGRL-1, a member of immunoglobulin gene superfamily |
| 09/05/2000 | US6114513 Medical diagnosis; transfer across cell membranes |
| 09/05/2000 | US6114509 Polypeptide with reduced allergenicity |
| 09/05/2000 | US6114507 A neutralizing antibody that supresses ligand induced apoptosis; therapy of hepatitis b, hepatitis c, human immunodeficiency virus infections |
| 09/05/2000 | US6114506 Composition and method for enhancing fibrinolysis |
| 09/05/2000 | US6114505 A genetically engineered globin-like subunit which produces stability and increases heme affinity; therapy and increase blood availability for transfusions |
| 09/05/2000 | US6114504 Use of thiol redox proteins for reducing protein intramolecular disulfide bonds, for improving the quality of cereal products, dough and baked goods and for inactivating snake, bee and scorpion toxins |
| 09/05/2000 | US6114502 Gene family associated with neurosensory defects |
| 09/05/2000 | US6114390 An argininamide or ornithinamide compound as treating memory loss, migraine, sleep disorders, pain, cardiovascular diseases, subarachnoidal bleeding, vascular-hypertrophic changes, cerebral and coronary vasospasms |
| 09/05/2000 | US6114388 Monofunctional and/or polyfunctional polylysine conjuages |
| 09/05/2000 | US6114376 Reversing agent is ll-f28249alpha-lambda series of compounds, the 23-oxo or 23-imino derivative thereof, the avermectins, the 22,23-dihydro derivatives thereof and the milbemycins |
| 09/05/2000 | US6114358 Thrombin inhibitors |
| 09/05/2000 | US6114311 Administering an adenviral compound |
| 09/05/2000 | US6114310 Efflux pump inhibitors |
| 09/05/2000 | US6114308 Inhibitors of trypsin-like enzymes |
| 09/05/2000 | US6114307 Methods for stimulating pancreatic islet cell regeneration |
| 09/05/2000 | US6114306 Cytokine related to hemolytic anemia and method of use |
| 09/05/2000 | US6114305 Utilization of prolactin for preventing and/or treating the expression of brooding behavior in birds |
| 09/05/2000 | US6114304 Administering an amylin agonist such as pramlintide or pramlintide acetate; reducing gastric motility or delaying gastric emptying |
| 09/05/2000 | US6114303 Therapy for hypotension |
| 09/05/2000 | US6114180 Human cardiac troponin |
| 09/05/2000 | US6114167 Cell having a viral vector producing a non-naturally occurring rna targeted to moloney murine leukemia virus or human immunodeficiency virus; infection resistant cells |
| 09/05/2000 | US6114166 Human pluripotent hematopoietic colony stimulating factor and cell line producing same |
| 09/05/2000 | US6114161 Isolated streptococcus sp pt strain dsm 8747 which produces a lipoteichoic acid used as an anticarcinogenic agent |
| 09/05/2000 | US6114159 DNA sequences for matrix metalloproteases, their production and use |
| 09/05/2000 | US6114146 Transfecting eukaryotic cell line which expresses endogenous dihydrofolate reductase with plasmid having dicistronic transcription/translation unit, isolating and amplifying clones, obtaining expressed protein in high purity and yield |
| 09/05/2000 | US6114145 Nucleic acid encoding a polypeptide having antiviral activity, bone marrow colony formation activity, and can inhibit colony stimulating factor proliferation of a erythroleukemic cell line; for therapy of immune system disorders |
| 09/05/2000 | US6114144 Isolation of a gene encoding human thyrotropin β subunit |
| 09/05/2000 | US6114143 Anti-HIV monoclonal antibody |
| 09/05/2000 | US6114140 Nucleotide sequences that code protein with enzymatic activity; for detecting proteins which bind hydrolase enzymes; antiproliferative agents; anticarcinogenic agents |
| 09/05/2000 | US6114108 Methods and compositions for the selective modification of viral nucleic acids |
| 09/05/2000 | US6113951 Use of thiol redox proteins for reducing protein intramolecular disulfide bonds, for improving the quality of cereal products, dough and baked goods and for inactivating snake, bee and scorpion toxins |
| 09/05/2000 | US6113948 Microparticles and their use in wound therapy |
| 09/05/2000 | US6113947 Controlled release microencapsulated NGF formulation |
| 09/05/2000 | US6113943 Active substance with hydrolyzed lactic acid polymer |
| 09/05/2000 | US6113915 Methods for treating pain |
| 09/05/2000 | US6113914 Osp A proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines |
| 09/05/2000 | US6113911 Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation method |
| 09/05/2000 | US6113906 Water-soluble non-antigenic polymer linkable to biologically active material |
| 09/05/2000 | US6113905 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases |
| 09/05/2000 | US6113904 Polypeptide with amino acid sequences |
| 09/05/2000 | US6113903 Antidiabetic agents |
| 09/05/2000 | US6113900 Use of IL-2 receptor-targeted therapeutics to inhibit allograft rejection and treat autoimmune disorders |
| 09/05/2000 | US6113899 Antagonists of chaperonin 10 |
| 09/05/2000 | US6113898 Human B7.1-specific primatized antibodies and transfectomas expressing said antibodies |
| 09/05/2000 | US6113897 Antibodies and their use |
| 09/05/2000 | US6113896 Serine protease inhibitors which inhibit factor x |
| 09/05/2000 | US6113629 Hydrogel for the therapeutic treatment of aneurysms |
| 09/05/2000 | CA2186122C C-terminally truncated cftr genes and proteins |
| 09/05/2000 | CA2083683C Stable formulation of analapril salt, a process for the preparation thereof and the use thereof |
| 09/05/2000 | CA2082928C Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions |
| 09/05/2000 | CA2057058C Monoclonal antibodies to c-reactive protein |
| 09/05/2000 | CA2006596C Chemically-modified g-csf |
| 09/05/2000 | CA1341091C Regulation of gene expression by employing translational inhibition utilizaing mrna interfering complementary rna |
| 09/02/2000 | CA2299893A1 Hiv therapy |
| 08/31/2000 | WO2000050897A1 Compounds and methods for the detection and prevention of t. cruzi infection |
| 08/31/2000 | WO2000050641A1 T CELL RECEPTOR Vβ-Dβ-Jβ SEQUENCE AND METHODS FOR ITS DETECTION |
| 08/31/2000 | WO2000050638A1 Diagnosis and therapy of premature ovarian failure |
| 08/31/2000 | WO2000050633A1 Method for cloning signal transduction intermediates |
| 08/31/2000 | WO2000050620A2 Human endokine alpha and methods of use |
| 08/31/2000 | WO2000050618A1 Virus vector |
| 08/31/2000 | WO2000050617A1 Intravascular delivery of non-viral nucleic acid |
| 08/31/2000 | WO2000050608A1 Novel polypeptide |
| 08/31/2000 | WO2000050607A2 Goodpasture antigen binding protein |
| 08/31/2000 | WO2000050602A1 Tdk polypeptides and polynucleotides and methods thereof |
| 08/31/2000 | WO2000050597A2 Neutrokine-alpha and neutrokine-alpha splice variant |
| 08/31/2000 | WO2000050590A1 Mdm interacting protein and methods of use thereof |
| 08/31/2000 | WO2000050589A1 TYROSINE KINASE RECEPTOR EphA3 ANTIGENIC PEPTIDES |
| 08/31/2000 | WO2000050588A2 Genes associated with diseases of the colon |
| 08/31/2000 | WO2000050584A2 Methods and compositions for enhancing in vivo gene delivery/expression |
| 08/31/2000 | WO2000050580A2 Composition, methods and reagents for the synthesis of a soluble form of human phex |
| 08/31/2000 | WO2000050577A1 Drug design based on the structure of lta4 hydrolase |
| 08/31/2000 | WO2000050574A1 Compositions and methods for modulating serum cholesterol |
| 08/31/2000 | WO2000050565A2 Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene |
| 08/31/2000 | WO2000050460A1 Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists thereof, and their therapeutic uses |
| 08/31/2000 | WO2000050459A1 Human tumor necrosis factor receptor-like proteins tr11, tr11sv1, and tr11sv2 |
| 08/31/2000 | WO2000050456A2 Covalently bridged insulin dimers |
| 08/31/2000 | WO2000050454A1 Androgen-induced suppressor of cell proliferation and uses thereof |
| 08/31/2000 | WO2000050453A1 A novel inhibitor of programmed cell death |
| 08/31/2000 | WO2000050452A1 Mutants of rac protein |
| 08/31/2000 | WO2000050451A2 Protein (tp) that is involved in the development of the nervous system |
| 08/31/2000 | WO2000050450A1 Mite protein |
| 08/31/2000 | WO2000050449A1 Process for production diphtheria toxin |
| 08/31/2000 | WO2000050447A1 Carbohydrate epitope mimic peptides and uses thereof |
| 08/31/2000 | WO2000050445A1 Novel component of von hippel-lindau tumor suppressor complex and scf ubiquitin ligase |
| 08/31/2000 | WO2000050443A2 Secreted proteins and uses thereof |
| 08/31/2000 | WO2000050442A2 Secreted proteins and uses thereof |
| 08/31/2000 | WO2000050440A1 ANTISENSE MODULATION OF Smad5 EXPRESSION |
| 08/31/2000 | WO2000050439A1 ANTISENSE MODULATION OF Smad4 EXPRESSION |
| 08/31/2000 | WO2000050438A1 Antisense modulation of phospholipase a2 group iv expression |